Ketamine Provider Continuity of Care: Key Questions

Why Continuity of Care Matters With Ketamine Treatment

Continuity of care means the same clinician or a coordinated care team tracks your treatment over time, reviewing how you're responding, communicating with your other providers, and adjusting the plan as needed, rather than treating each ketamine session as a one-off appointment. For ketamine therapy, this matters because most protocols involve an initial series of sessions followed by a maintenance phase, and your response can shift from one visit to the next. A provider who doesn't track that trajectory, or who can't explain how they coordinate with your therapist or prescribing psychiatrist, may not be positioned to catch a problem early or adjust your plan when it stops working.

The U.S. Food and Drug Administration (FDA), the federal agency that reviews and approves prescription drugs, has approved ketamine in only one form: esketamine (brand name Spravato), for treatment-resistant depression used alongside an oral antidepressant. Nearly every other use of ketamine for depression, anxiety, post-traumatic stress disorder, or other mental health conditions is off-label, meaning a licensed prescriber is applying clinical judgment outside the drug's FDA-approved indication. If you want the background on how ketamine and esketamine differ, that distinction affects how much structured follow-up care is built into treatment by default. Because esketamine's approval came with a mandated risk evaluation and mitigation program, but off-label ketamine has no equivalent federal requirement, the strength of your follow-up care depends almost entirely on the individual provider or clinic you choose.

What "Continuity of Care" Actually Covers

Continuity of care isn't a single feature, it's a bundle of practical arrangements that determine whether your treatment stays coordinated and safe over months, not just during a single dosing session. Before you commit to a provider, it helps to break the concept down into specific pieces you can ask about directly. These pair well with the broader ketamine provider safety protocols to verify before treatment.

Prescriber and clinician consistency

Ask whether the same physician, nurse practitioner, or psychiatric team will oversee your care across the full course of treatment, or whether you'll see a rotating group of clinicians. Consistency matters because a clinician who has seen your baseline symptoms and past responses is better positioned to recognize a meaningful change, for better or worse, than one meeting you for the first time at each visit.

Communication with your therapist or primary care doctor

Ketamine is rarely a stand-alone treatment. Many protocols pair it with talk therapy or ongoing psychiatric medication management. A 2017 consensus statement in JAMA Psychiatry, published by a multi-institution panel of ketamine researchersrecommended close coordination between ketamine prescribers and a patient's broader mental health team. Ask whether the provider will send visit summaries to your therapist or primary care physician, with your written consent, or whether that coordination is left entirely up to you.

Maintenance and booster session planning

Ketamine's effects on depression and other conditions are often described in the research literature as time-limited, with symptoms sometimes returning weeks or months after an initial series ends. Ask what the provider's plan is for maintenance dosing: how they decide if and when you need a booster session, who makes that call, and what it typically costs. Our guide on what happens when patients stop or taper ketamine treatment covers how relapse and discontinuation are usually handled.

A plan for problems between sessions

Ask how you reach the provider if you have a side effect, a mental health crisis, or a question between scheduled visits. Look for a specific answer, an on-call clinician, a documented after-hours protocol, a partnership with a local emergency service, rather than a vague assurance. Our guide to how ketamine providers handle adverse reactions during treatment covers what a well-structured response plan should include.

Continuity of Care Looks Different at Home Versus in a Clinic

At-home telehealth ketamine programs and in-person clinics both offer continuity of care, but the mechanics differ, and it's worth asking model-specific questions. In a clinic, a nurse or physician is typically present during dosing and can respond immediately if something goes wrong; continuity often comes from staff who see you repeatedly and coordinate care on-site. In an at-home telehealth model, dosing usually happens without a clinician physically present, so continuity depends more heavily on how well the platform documents your sessions, checks in with you, and stays reachable when you need help. If you're weighing a telehealth option, our guide to evaluating an at-home ketamine provider walks through additional screening questions specific to that model.

Bringing These Questions Into Your First Conversation

You don't need clinical terminology to ask good continuity-of-care questions, you need specific answers, not general reassurance. If an intake coordinator can't answer a question about follow-up care, ask to speak with a clinician before you book your first appointment. It's also reasonable to ask the same set of questions to two or three providers so you can compare their answers side by side, the way you would with any recurring medical service. For a broader walkthrough of a first conversation with a ketamine provider, see our getting started guide to ketamine therapy. And if you're weighing whether ketamine is the right fit for you long-term, our overview of ketamine and esketamine side effects and what discontinuation looks like covers what to expect if you eventually stop treatment.

This article is educational and not a substitute for individual medical advice. Talk with a licensed clinician about your own health history, current medications, and treatment goals before starting or changing any ketamine protocol.